| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21c08c0f5b7157094b9165e9c2ec46f1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2006-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78788ad767ff9443ad192fa7491a2df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f01e483f9558bd0af658939f6f5a4c7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_916b5a54d950ff6e85aad79dd82b5b2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c78d15aeab4715151add3affb943fb2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_503d14d5bcc551985dbadb46aa2d989a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8ebe51b830a5a592bca3653bd7f481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb5d18427104bdf6d18dc6222f0be3c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb828d56f0915ab84078880a04e710e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9afff0d64874d8e6d3c7073e68e9834c |
| publicationDate |
2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007031403-A1 |
| titleOfInvention |
Interferon-gamma inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use |
| abstract |
A human IFN-γ inducing polypeptide and its nucleotide sequence was isolated, purified and characterized. Pharmaceutical compositions containing this novel INF-γ inducing polypeptide or active fragments thereof are formulated and monoclonal antibodies are raised against this polypeptide or antigenic fragments thereof. The polypeptide can be used in a method for treating diseases susceptive to treatment with INF-γ, and methods for enhancing the cytotoxicity of NK cells or for inducing the formation of LAK cells, such as to treat tumors and malignant pathologies. |
| priorityDate |
1994-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |